CNBX Pharmaceuticals Inc.
CNBX
$0.00
$0.000.00%
OTC PK
| 11/30/2025 | 08/31/2025 | 05/31/2025 | 02/28/2025 | 11/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -393.30K | -314.00K | -224.50K | -295.40K | -551.10K |
| Total Depreciation and Amortization | -- | -- | 0.00 | 0.00 | 32.90K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 83.00K | 39.80K | 56.50K | 42.30K | 202.10K |
| Change in Net Operating Assets | 130.60K | 102.80K | -23.00K | 114.30K | 104.60K |
| Cash from Operations | -179.60K | -171.30K | -191.10K | -138.90K | -211.60K |
| Capital Expenditure | -- | -- | 0.00 | 0.00 | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | 0.00 | 94.70K | 114.70K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | 0.00 | 94.70K | 114.70K |
| Total Debt Issued | 170.00K | 160.00K | 131.30K | 112.60K | 32.60K |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 170.00K | 160.00K | 131.30K | 112.60K | 32.60K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -59.90K | 0.00 |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -9.60K | -11.30K | -59.80K | 8.50K | -64.30K |